COVID-19: Ramdev Baba’s Patanjali Sends Papers On ‘Coronil’ Clinical Trial To Ministry Of AYUSH
The AYUSH Ministry has also requested the Uttarakhand State Licensing Authority to provide copies of the license and product approval details of the ayurvedic medicine.
On June 23, yoga guru Ramdev’s Patanjali Ayurved Ltd.,launched what they claimed was the first Ayurvedic medicine to cure COVID-19. However, the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy) had sought details about the medicine and directed Patanjali and Ramdev to stop advertising such claims. The AYUSH Ministry had also requested the Uttarakhand State Licensing Authority to provide copies of the license and product approval details of the Ayurvedic medicines which the company has claimed will treat COVID-19.
Patanjali Ayurved has sent its documents on the clinical trial of ‘Coronil’ Coronavirus medicine to AYUSH Ministry. Patanjali Research Foundation Trust sent the documents in response to the queries raised on the recent clinical trial that Baba Ramdev claimed was 100 per cent successful in curing COVID-19 patients. On Tuesday, the AYUSH Ministry asked Ramdev’s Patanjali Ayurved to provide, “at the earliest,” details of composition and research undertaken prior to the launch of the medicines it claimed are for the treatment of COVID-19, and advised Patanjali to stop advertising them until the “issue” is examined.
Get more news updates on ZEE5.